Quick Takeaways
- ORBIMED ADVISORS LLC filed SCHEDULE 13D for Shattuck Labs, Inc. Common Stock, par value $0.0001 per share (STTK).
- Disclosed ownership: 10%.
- Date of event: 25 Aug 2025.
ORBIMED ADVISORS LLC - 25 Aug 2025 SCHEDULE 13D Report for Shattuck Labs, Inc. Common Stock, par value $0.0001 per share (STTK)
- Filing Manager
- ORBIMED ADVISORS LLC
- Reporting Manager
- ORBIMED ADVISORS LLC
- Symbol
- STTK
- Shares outstanding
- 63,124,394 shares
- Disclosed Ownership
- 6,306,127 shares
- Ownership
- 10%
- Form type
- SCHEDULE 13D
- Filing time
- 02 Sep 2025, 21:53:10 UTC
- Date of event
- 25 Aug 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"ORBIMED ADVISORS LLC disclosed 10% ownership in Shattuck Labs, Inc. Common Stock, par value $0.0001 per share (STTK) on 25 Aug 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 02 Sep 2025, 21:53.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 10% | 6,306,127 | 0 | 6,306,127 | /s/ Carl L. Gordon | Carl L. Gordon/Member | 0001055951 |
| OrbiMed Capital GP IX LLC | 8.3% | 5,255,106 | 0 | 5,255,106 | /s/ Carl L. Gordon | Carl L. Gordon/Member of OrbiMed Advisors LLC | 0001920574 |
| OrbiMed Genesis GP LLC | 1.7% | 1,051,021 | 0 | 1,051,021 | /s/ Carl L. Gordon | Carl L. Gordon/Member of OrbiMed Advisors LLC | 0001808744 |